Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
101206 | Cevipabulin | 849550-05-6 | 98% | |
Cevipabulin is a novel, potent, synthetic small molecule, inhibits binding of vinblas | ||||
100904 | CHS-828 | 200484-11-3 | 98% | |
CHS-828, also known as GMX-1778, is a potent and selective NAMPT inhibitor. CHS-828 i | ||||
91303 | CUDC-101 | 1012054-59-9 | 98% | |
CUDC-101 is a novel, small-molecule, anticancer agent targeting histone deacetylase ( | ||||
92218 | CB52682315 | 98% | ||
Coming soon! | ||||
92205 | 5-Chloro-2-Fluoro-4-Iodopyridine | 659731-48-3 | 98% | |
5-Chloro-2-Fluoro-4-Iodopyridine | ||||
91824 | Cas No.1542139-04-7 | 1542139-04-7 | 98% | |
Coming soon! | ||||
91403 | Cis-5-Norbornene-Endo-2,3-Dicarboxylic | 129-64-6 | 98% | |
The related APILurasidone hydrochlorideThe related intermediates4-(1,2-Benzothiazol-3 | ||||
90619 | 3-(4-Chloro-3-fluorophenyl)propionic acid | 881189-65-7 | 98% | |
Coming soon! | ||||
90617 | 3-(4-CARBOXYPHENYL)PROPIONIC ACID | 38628-51-2 | 98% | |
Coming soon! | ||||
90615 | 3-(4-Chlorophenyl)propanoic acid | 2019-34-3 | 98% | |
Coming soon! | ||||
90614 | 3-(2-Chlorophenyl)Propionic Acid | 1643-28-3 | 98% | |
Coming soon! | ||||
90612 | 3-(4-CYANOPHENYL)PROPANOIC ACID | 42287-94-5 | 98% | |
Coming soon! | ||||
90611 | 3-Cyanobenzenepropanoic acid | 42287-97-8 | 98% | |
Coming soon! | ||||
83102 | 2-(4-Chlorophenyl)pyrrolidine | 38944-14-8 | 98% | |
Coming soon! | ||||
82725 | 2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7-one | 1013916-37-4 | 98% | |
Coming soon! | ||||
82716 | 3-chloro-4-(pyridin-2-ylmethoxy)aniline | 524955-09-7 | 98% | |
Coming soon! | ||||
81934 | 6-Chloro-1-Indanone | 14548-38-0 | 98% | |
Coming soon! | ||||
81804 | (Cbz-4-aminomethyl)piperidine | 132431-09-5 | 98% | |
Coming soon! | ||||
81735 | 1-Cbz-3-aminopyrrolidine hydrochloride | 1159822-27-1 | 98% | |
Coming soon! | ||||
81309 | 2-Cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde | 121660-37-5 | 98% | |
Related API & intermediates:Cas#147526-32-7 Pitavastatin CalciumCas# 24922-02-9 E | ||||
81308 | [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido | 154057-58-6 | 98% | |
Related API & intermediates:Cas#147526-32-7 Pitavastatin CalciumCas# 24922-02-9 E | ||||
81307 | 2-Cyclopropyl-3-[(diphenylphosphinyl)methyl]-4-(4-fluorophenyl)quinolin | 146578-99-6 | 98% | |
Related API & intermediates:Cas#147526-32-7 Pitavastatin CalciumCas# 24922-02-9 E | ||||
81305 | (2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methanol | 121660-11-5 | 98% | |
Related API & intermediates:Cas#147526-32-7 Pitavastatin CalciumCas# 24922-02-9 E | ||||
81004 | 3-Chloro-4-methoxybenzaldehyde | 4903-09-7 | 97% | |
Cooming soon! | ||||
73105 | CEP-33779 | 1257704-57-6 | 97% | |
CEP33779 is a selective JAK2 inhibitor with IC50 of 1.8 nM. CEP33779(< 3 M) inhibi | ||||
73104 | CID755673 | 521937-07-5 | 97% | |
CID 755673 is a selective and potent protein kinase D1-D3, PKC, CAK, PLK1 and CAMKII | ||||
73103 | CGI-1746 | 910232-84-7 | 97% | |
CGI1746 is a potent and highly selective small-molecule inhibitor of the Btk with IC5 | ||||
72804 | CPI-169(racemate) | 1450655-76-1 | 97% | |
CPI-169 racemate is the racemate form of CPI-169, which is a novel and potent EZH2 in | ||||
72001 | CHZ868(CHZ-868) | 1895895-38-1 | 98% by HPLC | |
CHZ868,a type II JAK inhibitor, would demonstrate activity in JAK inhibitor persisten | ||||
71805 | Capivasertib ( AZD5363 ) | 1143532-39-1 | 98% | |
Capivasertib is a novel pyrrolopyrimidine derivative, and an orally available inhibit |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1